Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 55.60
+2.50 (4.71%)
At close: Oct 8, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.23 billion as of October 9, 2026. It is the 25,321st most valuable company in the world and the 1,359th biggest in Taiwan. Its market cap has decreased by 22.89% in one year.
Market Cap
3.23B
Enterprise Value
2.93B
Revenue
265.54M
Global Rank
Country Rank
#1,359 Taiwan
PE Ratio
107.93
ChartMarket Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.23B, an increase of 132.00%. That is a compound annual growth rate of 46.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 3.23B | -9.89% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 23.31B |
| Elixiron Immunotherapeutics (Cayman) Limited | 19.60B |
| Obigen Pharma | 9.28B |
| Intelligene | 7.98B |
| Uwell Biopharma | 5.70B |
| Tripartite Therapeutics | 5.34B |
| BIONET Therapeutics | 2.60B |
| Genomics BioSci & Tech. | 1.31B |